Business Wire

First Patient Treated on Mevion's Next Generation Proton Therapy System

Del

Mevion Medical Systems announces the treatment of the first patient in the world on the MEVION S250i Proton Therapy System® at MedStar Georgetown University Hospital in Washington, D.C.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180402005234/en/

The MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning at MedStar Georgetown Uni ...

The MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning at MedStar Georgetown University Hospital in Washington, D.C. (Photo: Business Wire)

“The launch of the HYPERSCAN system is a major milestone in the field of proton therapy. It is the realization of a vision to create the most clinically advanced and economically viable proton therapy system in the world making proton therapy accessible across the spectrum of healthcare providers,” said Joseph Jachinowski, CEO of Mevion Medical Systems. “Mevion has consistently pushed the field of proton therapy forward. We first changed proton therapy by introducing a new paradigm of economic, compact proton systems and now we are doing it again by deploying an advanced approach to pencil beam delivery. These achievements are the result of a team passionate about the impact proton therapy can have on patients’ lives.”

New Clinical Capabilities
Proton therapy is a precise form of radiation therapy that has the potential to reduce the amount of radiation exposure in some cancers. The Mevion system at MedStar Georgetown includes HYPERSCAN™ pencil beam scanning (PBS) which improves on existing proton scanning capabilities enabling clinicians to deliver conformal fields faster and with more precision than in the past.

The HYPERSCAN system utilizes a novel technology, the Adaptive Aperture™, a proton multi-leaf collimator (pMLC), to achieve sharp lateral dose gradients. Multi-leaf collimators are common to conventional radiation therapy and were a key enabling technology to make intensity modulated radiation therapy (IMRT) possible. Mevion’s Adaptive Aperture pMLC is unique to proton therapy. Designed to protect sensitive organs at every energy layer of the treatment, this new type of proton MLC enables a similar paradigm change in proton therapy.

Uptick in Global Adoption
In addition to MedStar Georgetown, the MEVION S250i™ system is under active installation at centers throughout the US and Europe. Two more HYPERSCAN centers will be treating patients by the end of 2018. An additional two centers are in the construction planning phase, both of which are instances of existing sites adding a second treatment room.

“We are excited to see the rapid adoption of Mevion’s HYPERSCAN technology,” said Yoel Bakas, senior vice president of sales for Mevion Medical Systems. “Proton therapy has long been viewed as economically unrealistic for most cancer centers. The uptick in proton projects and repeat customers speaks to the strength of the Mevion economic and clinical approach.”

Integration and Economics in Proton Therapy
At Medstar Georgetown, the proton system is integrated directly to the hospital as part of a renovation to the existing cancer center entrance. While other proton centers often have to be built as separate standalone facilities, the compact size of the Mevion system enables it to be integrated to existing radiation oncology departments. This can bring significant economic savings to these projects by enabling the centers to share existing support services and personnel throughout the hospital rather than duplicating them in a standalone facility.

Proton Therapy Symposium at ESTRO 37
Mevion will be hosting a luncheon symposium at the annual European Society for Radiotherapy and Oncology (ESTRO) in Barcelona Spain on Saturday April 21st. Attendees are invited to come learn more about HYPERSCAN pencil beam scanning and compact Mevion proton therapy systems. A panel of speakers will be discussing the implementation of these projects and the clinical experiences of the HYPERSCAN system.

About Mevion Medical Systems®
Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with presence in Europe and China. For more information, please visit www.mevion.com.

Follow Mevion on Twitter: https://twitter.com/mevionmedical

Connect with Mevion on LinkedIn: https://www.linkedin.com/company/mevion-medical-systems

Contact information

Mevion
Melanie Benton, 978-540-1551
mbenton@mevion.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

TimeXtender Discovery Hub® is Now Microsoft Azure Certified26.4.2018 14:00Pressemelding

TimeXtender, a recognized global software company enabling instant access to any type of data in the organization to support advanced analytics and artificial intelligence (AI), today announced that its Discovery Hub® solution has been tested, approved and certified for readiness and compatibility to run in Microsoft Azure environments. With this certification, Discovery Hub® is now a trusted application that is available in the Microsoft Azure Marketplace. The Azure Marketplace is an extensive catalog of products from independent software vendors (ISVs). Azure Marketplace allows IT professionals and developers to confidently search for Microsoft Azure certified products and solutions. “To be published in the Azure Marketplace, a solution goes through a number of certification steps to validate the platform, solution and software,” said Heine Krog Iversen, CEO at TimeXtender. “Given these requirements, we’re pleased that Discovery Hub® has been certified to run on Microsoft Azure. This

Andersen Global Announces Collaboration in Peru26.4.2018 13:30Pressemelding

Andersen Global continues its expansion in Latin America through a Collaboration Agreement with Picon & Asociados, a tax and legal practice that encompasses a full range of private and corporate services. Picon & Asociados, located in Lima, enhances Andersen’s provision of best-in-class service globally. Jorge Picon leads the team in Peru. “Picon & Asociados is an excellent fit for our global organization and the collaboration addresses another key market in South America,” remarked Mark Vorsatz, Global Chairman and Andersen Tax LLC CEO. “The practice, which includes nearly 40 professionals, provides us with added legal capabilities and enhances our core tax business in the region.” Jorge added, “Creating value for our clients by providing high quality, specialized tax and legal services is a top priority, and working with professionals that share this mindset is very important to us. Our team is committed to providing best-in-class solutions for our clients and we look forward to coll

Speech Processing Solutions Signs ORdigiNAL to Increase Channel Distribution in UK & Ireland of its Voice-to-Text Hardware, Software and Cloud Solutions26.4.2018 11:00Pressemelding

Speech Processing Solutions, the world number one in professional dictation, is delighted to announce a new partnership with ORdigiNAL, a leading European distributor of speech recognition, dictation, document creation and telephony products. ORdigiNAL will act as specialist distributor in the UK and Ireland for Philips’ professional dictation hardware, software and cloud services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180426005787/en/ Philips Dictation (Photo: Business Wire) As part of the agreement, ORdigiNAL will supply Philips’ digital voice recorders, voice-to-text workflow software for small business and Enterprise, speech recognition solutions, and Cloud transcription services to resellers and integrators, especially those operating in the medical and legal markets. Philips’ voice technology comprehensive portfolio include digital recording hardware, speech recognition and dictation workflow software and clou

BIOCAD: Interleukin-17 Inhibitor Shows High Efficacy After One Year of Therapy in Psoriasis Patients26.4.2018 09:08Pressemelding

In March 2018, BIOCAD analyzed results from its Phase II study in which the original Russian IL-17 inhibitor proved highly effective in long-term therapy in patients with severe psoriasis. The drug also showed great results in the treatment of ankylosing spondylitis. BCD-085 is an original monoclonal antibody drug blocking interleukin-17, a cytokine playing a key role in developing and maintaining various autoimmune and immunoinflammatory diseases. The majority of psoriasis patients have serious psychological problems due to social isolation, while patients with ankylosing spondylitis may rapidly become disabled if diagnosed late or treated inappropriately. Both diseases are a serious medical and social challenge, especially because they often affect young people of working age (22 to 35 years old). The European market of IL-17 inhibitors is over $700 million and it’s going to grow to $1 677 million within next 5 years. BIOCAD expects to occupy an essential share of this perspective ma

Ecole hôtelière de Lausanne (EHL) Wins Best Employer Ranking26.4.2018 08:17Pressemelding

Ecole hôtelière de Lausanne (EHL) wins the title of Best Employer in French-speaking Switzerland in the category of medium-sized companies in the annual ranking of the magazine Bilan published this week. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180426005645/en/ Ecole hôtelière de Lausanne (EHL) Offering a dynamic and pleasant work environment on the campus north of Lausanne, the 464 employees of 33 nationalities benefit, among other things, from home-office opportunities, seven weeks of vacation, access to sport facilities and up to three free meals a day. Reacting to the announcement, CEO of the EHL Group, Mr Rochat said "the quality of the work environment is one of the priorities set for the EHL management. It is important for us to be able to attract and retain the best talent to continue to provide the best training to our students, and maintain our leadership position in teaching Hospitality Management. We work o

Alibaba Cloud Receives MySQL Corporate Contributor Award26.4.2018 08:00Pressemelding

Alibaba Cloud, the cloud computing arm of Alibaba Group, has won the 2018 MySQL Community Awards: Corporate Contributor, which recognizes its contribution to the MySQL ecosystem, the world’s most popular open source database. The award, presented earlier this week at the Percona Live conference held in Santa Clara, California, is another accolade for the global cloud services provider. The award recognized Alibaba Cloud’s contributions to the open source communities and its efforts to empower developers around the world in recent years. Today, more than one hundred thousand MySQL instances are running on ApsaraDB for RDS, Alibaba Cloud’s relational database services. This is the second time Alibaba has received the coveted award from the MySQL community. In 2015, Alibaba Group became the first Asian company to be named a WebScaleSQL Contributor, alongside Facebook, Google, Twitter and LinkedIn. The award is a ‘from-the-community, by-the-community, and for-the-community’ initiative and